SCHEMBL650797

SCHEMBL650797

COc1cncc(N2C[C@@H]3CCN(C(=O)OC(C)(C)C)[C@@H]3C2)c1

nearest known ligand 0.49

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 9/20 0.47
CHRNA4 P43681 9/20 0.47
CHRNB4 P30926 8/20 0.47
CHRNA3 P32297 8/20 0.47
GPR119 Q8TDV5 4/20 0.45
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
RET P07949 1/20 0.44
ALDH1A1 P00352 1/20 0.40
USP30 Q70CQ3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654584 1.00 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3GPR119
SCHEMBL652009 0.87 GPR119 (0.45) CHRNB2CHRNA4CHRNB4CHRNA3GPR119
SCHEMBL650737 0.86 GPR119 (0.43) CHRNB2CHRNA4CHRNB4CHRNA3GPR119
SCHEMBL650034 0.86 GPR119 (0.43) CHRNB2CHRNA4CHRNB4CHRNA3GPR119
SCHEMBL3580877 0.86 CHRNB2 (0.52) CHRNB2CHRNA4CHRNB4CHRNA3USP30
SCHEMBL3572184 0.86 CHRNB2 (0.52) CHRNB2CHRNA4CHRNB4CHRNA3USP30
SCHEMBL649506 0.84 RET (0.43) CHRNB4CHRNA3GPR119NR1H2NR1H3
SCHEMBL650661 0.84 NR1H2 (0.42) GPR119NR1H2NR1H3RETUSP30
SCHEMBL649486 0.84 NR1H2 (0.44) GPR119NR1H2NR1H3RETUSP30
SCHEMBL653685 0.84 RET (0.46) CHRNB2CHRNA4CHRNB4CHRNA3GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed